Acute Spinal Cord Injury (ASCI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019

GlobalData
May 31, 2012
65 Pages - SKU: GBDT3956795
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2014’, provides an overview of the Proliferative Diabetic Retinopathy (PDR)’s therapeutic pipeline. This report provides comprehensive information  |  read more...
USD 2,000
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014’, provides an overview of the Mucopolysaccharidosis I (MPS I) (Hurler Syndrome)’s  |  read more...
USD 2,000
Mycosis Fungoides - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Mycosis Fungoides - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Mycosis Fungoides - Pipeline Review, H2 2014’, provides an overview of the Mycosis Fungoides’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Mycosis  |  read more...
USD 2,000
Premature Labor (Tocolysis) - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Premature Labor (Tocolysis) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Premature Labor (Tocolysis) - Pipeline Review, H2 2014’, provides an overview of the Premature Labor (Tocolysis)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Germ Cell Tumors - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Germ Cell Tumors - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Germ Cell Tumors - Pipeline Review, H2 2014’, provides an overview of the Germ Cell Tumors’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Contact Dermatitis - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Contact Dermatitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Contact Dermatitis - Pipeline Review, H2 2014’, provides an overview of the Contact Dermatitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Contact  |  read more...
USD 2,000
Alcoholic Hepatitis - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Alcoholic Hepatitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Alcoholic Hepatitis - Pipeline Review, H2 2014’, provides an overview of the Alcoholic Hepatitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Alcoholic  |  read more...
USD 2,000
Corneal Graft Rejection - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Corneal Graft Rejection - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Corneal Graft Rejection - Pipeline Review, H2 2014’, provides an overview of the Corneal Graft Rejection’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023
11/1/2014 | published by: GlobalData
EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023 Summary Type 1 diabetes is a type of diabetes that accounts for 10% of all diabetes cases. The condition occurs as a result of the autoimmune destruction  |  read more...
USD 3,995
Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014’, provides an overview of the Hormone-Sensitive Prostate Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 3,995  
    Site License   USD 7,990  
    Global Site License  USD 11,985  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!